Education
About Us
Working with TipRanks
Follow Us
Elite Pharmaceuticals (ELTP)
OTHER OTC:ELTP
RESEARCH TOOLSreports
| Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 84.04M | $ 56.63M | $ 34.16B | $ 32.26M | $ 25.38M |
| Gross Profit | $ 40.09M | $ 26.36M | $ 16.59B | $ 14.80M | $ 11.87M |
| Operating Income | $ 19.60M | $ 10.79M | $ 2.03B | $ 5.07M | $ 2.10M |
| EBITDA | $ 2.84M | $ 2.58M | $ 6.43M | $ 6.27M | $ 5.93M |
| Net Income | $ -4.31M | $ 20.11M | $ 4.41B | $ 8.90M | $ 5.09M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 11.32M | $ 7.11M | $ 7.83M | $ 8.54M | $ 3.19M |
| Total Assets | $ 96.39M | $ 83.65M | $ 40.90M | $ 35.15M | $ 26.19M |
| Total Debt | $ 10.91M | $ 11.74M | $ 3.89M | $ 2.78M | $ 2.38M |
| Net Debt | $ -400.50K | $ 4.63M | $ -3.94M | $ -5.75M | $ -814.26K |
| Total Liabilities | $ 42.87M | $ 26.07M | $ 11.94M | $ 9.93M | $ 10.04M |
| Stockholders' Equity | $ 53.52M | $ 57.58M | $ 28.96M | $ 25.22M | $ 16.15M |
| Cash Flow | |||||
| Free Cash Flow | $ 4.93M | $ -4.09M | $ -2.40M | $ 6.01M | $ 2.86M |
| Operating Cash Flow | $ 7.46M | $ -3.28M | $ 3.34M | $ 6.51M | $ 3.19M |
| Investing Cash Flow | $ -2.40M | $ -809.65K | $ -5.74M | $ -498.57K | $ -262.78K |
| Financing Cash Flow | $ -825.74K | $ 3.39M | $ 1.70M | $ -667.13K | $ -869.83K |